NO20074825L - Piperidinylpiperazinderivater for anvendelse som inhibitorer av kjemokinreseptorer - Google Patents
Piperidinylpiperazinderivater for anvendelse som inhibitorer av kjemokinreseptorerInfo
- Publication number
- NO20074825L NO20074825L NO20074825A NO20074825A NO20074825L NO 20074825 L NO20074825 L NO 20074825L NO 20074825 A NO20074825 A NO 20074825A NO 20074825 A NO20074825 A NO 20074825A NO 20074825 L NO20074825 L NO 20074825L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- inhibitors
- compound
- treatment
- methods
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 2
- ZGABDPXDUGYGQE-UHFFFAOYSA-N 1-piperidin-1-ylpiperazine Chemical class C1CCCCN1N1CCNCC1 ZGABDPXDUGYGQE-UHFFFAOYSA-N 0.000 title 1
- 102000009410 Chemokine receptor Human genes 0.000 title 1
- 108050000299 Chemokine receptor Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 7
- 238000000034 method Methods 0.000 abstract 3
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 2
- 102100035875 C-C chemokine receptor type 5 Human genes 0.000 abstract 1
- 101710149870 C-C chemokine receptor type 5 Proteins 0.000 abstract 1
- 102000004274 CCR5 Receptors Human genes 0.000 abstract 1
- 108010017088 CCR5 Receptors Proteins 0.000 abstract 1
- 206010012438 Dermatitis atopic Diseases 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 230000007815 allergy Effects 0.000 abstract 1
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 206010003246 arthritis Diseases 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 201000008937 atopic dermatitis Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000024908 graft versus host disease Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 201000006417 multiple sclerosis Diseases 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/96—Sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Ved de mange utførelsesformene av den foreliggende oppfinnelse tilveiebringes en ny klasse forbindelser med strukturformel IA eller IB hvor R1-R8 er som beskrevet, hvor IA eller IB er inhibitorer av CCR5-reseptorer, fremgangsmåter for fremstilling av slike forbindelser, farmasøytiske preparater inneholdende en eller flere slike forbindelser, fremgangsmåter for fremstilling av farmasøytiske formuleringer omfattende én eller flere slike forbindelser, og fremgangsmåter for behandling, forhindring, inhibering eller lindring av én eller flere sykdommer forbundet med CCR5 ved å anvende slike forbindelser eller farmasøytiske preparater. Oppfinnelsen angår også anvendelse av en kombinasjon av en forbindelse ifølge oppfinnelsen og ett eller flere antivirale eller andre midler som er anvendelige ved behandling av humant immunsviktvirus (HIV). Oppfinnelsen angår også anvendelse av en forbindelse ifølge oppfinnelsen, alene eller i kombinasjon med et annet middel, ved behandling av avvisning av transplantert fast organ, "graft vs. host disease", artritt, reumatoid artritt, inflammatorisk tarmsykdom, atopisk dermatitt, psoriasis, astma, allergier eller multippel sklerose.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65557205P | 2005-02-23 | 2005-02-23 | |
PCT/US2006/006333 WO2006091692A1 (en) | 2005-02-23 | 2006-02-21 | Piperidinyl piperazine derivatives useful as inhibitors of chemokine receptors |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20074825L true NO20074825L (no) | 2007-10-17 |
Family
ID=36540289
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20074825A NO20074825L (no) | 2005-02-23 | 2007-09-21 | Piperidinylpiperazinderivater for anvendelse som inhibitorer av kjemokinreseptorer |
Country Status (17)
Country | Link |
---|---|
US (1) | US7659275B2 (no) |
EP (1) | EP1858887A1 (no) |
JP (1) | JP4769257B2 (no) |
KR (1) | KR20070107085A (no) |
CN (1) | CN101163695A (no) |
AR (1) | AR054740A1 (no) |
AU (1) | AU2006216731A1 (no) |
BR (1) | BRPI0609251A2 (no) |
CA (1) | CA2598651A1 (no) |
IL (1) | IL185395A0 (no) |
MX (1) | MX2007010258A (no) |
NO (1) | NO20074825L (no) |
PE (1) | PE20061012A1 (no) |
RU (1) | RU2411241C2 (no) |
TW (1) | TW200640910A (no) |
WO (1) | WO2006091692A1 (no) |
ZA (1) | ZA200707019B (no) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU229709B1 (en) | 2004-04-13 | 2014-05-28 | Incyte Corp Wilmington | Piperazinyilpiperidine derivatives as chemokine receptor antagonists |
KR100861024B1 (ko) * | 2007-07-20 | 2008-09-30 | 세크론 주식회사 | 반도체 제조 장치 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA01011116A (es) * | 1999-05-04 | 2002-06-04 | Schering Corp | Terapia de hiv de combinacion de antagonista ccr5 - interferon alfa pegilado. |
RU2299206C9 (ru) * | 1999-05-04 | 2007-11-20 | Шеринг Корпорейшн | Производные пиперазина, фармацевтические композиции, их содержащие, и применение в качестве антагонистов ccr5 |
US6689765B2 (en) * | 1999-05-04 | 2004-02-10 | Schering Corporation | Piperazine derivatives useful as CCR5 antagonists |
US6391865B1 (en) * | 1999-05-04 | 2002-05-21 | Schering Corporation | Piperazine derivatives useful as CCR5 antagonists |
US6387930B1 (en) * | 1999-05-04 | 2002-05-14 | Schering Corporation | Piperidine derivatives useful as CCR5 antagonists |
AR033517A1 (es) * | 2000-04-08 | 2003-12-26 | Astrazeneca Ab | Derivados de piperidina, proceso para su preparacion y uso de estos derivados en la fabricacion de medicamentos |
PL364560A1 (en) * | 2001-03-29 | 2004-12-13 | Schering Corporation | Ccr5 antagonists useful for treating aids |
IL157713A0 (en) * | 2001-03-29 | 2004-03-28 | Schering Corp | Aryl oxime-piperazines useful as ccr5 antagonists |
GB0223223D0 (en) * | 2002-10-07 | 2002-11-13 | Novartis Ag | Organic compounds |
PE20040769A1 (es) | 2002-12-18 | 2004-11-06 | Schering Corp | Derivados de piperidina utiles como antagonisas ccr5 |
JO2525B1 (en) * | 2004-04-08 | 2010-03-17 | شركة جانسين فارماسوتيكا ان. في | Derived 4-alkyl-and-4-canoelperidine derivatives and their use as anti-neroquin |
-
2006
- 2006-02-21 AR ARP060100621A patent/AR054740A1/es not_active Application Discontinuation
- 2006-02-21 JP JP2007557135A patent/JP4769257B2/ja not_active Expired - Fee Related
- 2006-02-21 BR BRPI0609251-9A patent/BRPI0609251A2/pt not_active IP Right Cessation
- 2006-02-21 KR KR1020077019808A patent/KR20070107085A/ko not_active Application Discontinuation
- 2006-02-21 AU AU2006216731A patent/AU2006216731A1/en not_active Abandoned
- 2006-02-21 EP EP06735837A patent/EP1858887A1/en not_active Withdrawn
- 2006-02-21 RU RU2007135126/04A patent/RU2411241C2/ru not_active IP Right Cessation
- 2006-02-21 CA CA002598651A patent/CA2598651A1/en not_active Abandoned
- 2006-02-21 CN CNA2006800137690A patent/CN101163695A/zh active Pending
- 2006-02-21 WO PCT/US2006/006333 patent/WO2006091692A1/en active Application Filing
- 2006-02-21 PE PE2006000210A patent/PE20061012A1/es not_active Application Discontinuation
- 2006-02-21 US US11/358,520 patent/US7659275B2/en not_active Expired - Fee Related
- 2006-02-21 MX MX2007010258A patent/MX2007010258A/es unknown
- 2006-02-22 TW TW095105989A patent/TW200640910A/zh unknown
-
2007
- 2007-08-20 IL IL185395A patent/IL185395A0/en unknown
- 2007-08-21 ZA ZA200707019A patent/ZA200707019B/xx unknown
- 2007-09-21 NO NO20074825A patent/NO20074825L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PE20061012A1 (es) | 2006-10-03 |
EP1858887A1 (en) | 2007-11-28 |
US20060223821A1 (en) | 2006-10-05 |
MX2007010258A (es) | 2007-09-11 |
TW200640910A (en) | 2006-12-01 |
WO2006091692A1 (en) | 2006-08-31 |
AU2006216731A1 (en) | 2006-08-31 |
CN101163695A (zh) | 2008-04-16 |
RU2007135126A (ru) | 2009-03-27 |
US7659275B2 (en) | 2010-02-09 |
JP4769257B2 (ja) | 2011-09-07 |
JP2008531575A (ja) | 2008-08-14 |
AR054740A1 (es) | 2007-07-11 |
CA2598651A1 (en) | 2006-08-31 |
BRPI0609251A2 (pt) | 2010-03-09 |
IL185395A0 (en) | 2008-02-09 |
ZA200707019B (en) | 2008-10-29 |
RU2411241C2 (ru) | 2011-02-10 |
KR20070107085A (ko) | 2007-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2010005292A (es) | Inhibidores de la replicacion del virus de la inmunodeficiencia humana. | |
RU2316553C2 (ru) | Производные пиперидина, фармацевтическая композиция на их основе и применение | |
NO20090327L (no) | Nye forbindelser 384 | |
BR0310106A (pt) | Composto, processo para a produção de um composto, composição farmacêutica, uso do composto e método para o tratamento de um sujeito em sofrimento de uma condição ou doença patalógica | |
CN113181339B (zh) | 一种醛基类化合物的药物用途 | |
NO20092529L (no) | Substituerte 2,3-dihydroimidazo[1,2-c]kinazolinderivater som er anvendbare for behandling av hyperproliferative forstyrrelser og sykdommer assosiert med angiogenese | |
NO20084845L (no) | 2-pyrazinonderivater for behandling av sykdom eller tilstander der inhibiering av neutrofil elastaseaktivitetet er gunstig | |
NO20082673L (no) | Nye 2-amino-imidazol-4-on forbindelser og deres anvendelse i fremstilling av et medikament som skal brukes til behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerasjon og demens | |
NO20064151L (no) | Nye forbindelser | |
MA35285B1 (fr) | Indazoles | |
NO20084872L (no) | 2-pyridonderivater for behandling av sykdom eller tilstander der inhibering av neutrofil elastaseaktivitet er gunstig | |
SE0104340D0 (sv) | New compounds | |
NO20075723L (no) | Tiazolforbindelser og fremgangsmater for anvendelse | |
NO20093464L (no) | Nye medikamentblandinger basert pa anti-cholinergisk effektive forbindelser og beta-mimetika | |
NO20083758L (no) | Nye terapautiske kombinasjoner for behandling av depresjon | |
NO20075042L (no) | Farmasoytisk sammensetning innbefattende en omega-karboksyarylsubstituert difenylurea for behandling av cancer | |
NO20074781L (no) | 4-Oksokinazolin-3-ylbenzamidderivater for behandling av cytokinsykdommer | |
GB2454615A (en) | Antidiabetic azabicyclo (3.1.0) hexan compounds | |
NO20073101L (no) | Nye pyridinforbindelser | |
NO20051900L (no) | Kinazolinderivater som SRC tyrosin kinase inhibitorer | |
AU2016382372A1 (en) | Sulfonamide derivative and preparation method and use thereof | |
JP2012206959A (ja) | グルコシダーゼ活性阻害用組成物及びそのスクリーニング方法 | |
JPH10501517A (ja) | ナフチルイソキノリンアルカロイド、それを含有する医薬組成物、およびそのマラリア治療のための使用 | |
NO20074825L (no) | Piperidinylpiperazinderivater for anvendelse som inhibitorer av kjemokinreseptorer | |
WO2008106125A3 (en) | Deuterated derivatives of silodosin as alpha la-adrenoceptor antagonists |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |